
Cancer Cell, Journal Year: 2017, Volume and Issue: 31(2), P. 172 - 179
Published: Feb. 1, 2017
Language: Английский
Cancer Cell, Journal Year: 2017, Volume and Issue: 31(2), P. 172 - 179
Published: Feb. 1, 2017
Language: Английский
Nature Reviews Clinical Oncology, Journal Year: 2018, Volume and Issue: 15(6), P. 353 - 365
Published: March 29, 2018
Language: Английский
Citations
509Science Translational Medicine, Journal Year: 2015, Volume and Issue: 7(313)
Published: Nov. 11, 2015
ESR1 mutations evolve during the treatment of metastatic breast cancer.
Language: Английский
Citations
505Nature Reviews Clinical Oncology, Journal Year: 2015, Volume and Issue: 12(7), P. 381 - 394
Published: April 21, 2015
Language: Английский
Citations
501Cell, Journal Year: 2017, Volume and Issue: 168(4), P. 584 - 599
Published: Feb. 1, 2017
Early successes in identifying and targeting individual oncogenic drivers, together with the increasing feasibility of sequencing tumor genomes, have brought forth promise genome-driven oncology care. As we expand breadth depth genomic analyses, biological clinical complexity its implementation will be unparalleled. Challenges include target credentialing validation, implementing drug combinations, trial designs, heterogeneity, deploying technologies beyond DNA sequencing, among others. We review how contemporary approaches are tackling these challenges ultimately serve as an engine for discovery increase our insight into cancer treatment.
Language: Английский
Citations
467Cancer Cell, Journal Year: 2017, Volume and Issue: 31(2), P. 172 - 179
Published: Feb. 1, 2017
Language: Английский
Citations
445